Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian P Bates

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
Journal of Proteome Research|March 4, 2006
Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopyTsz M Tsang, Ben Woodman, Gerard A McLoughlin, et al.
Nature Genetics|January 18, 2005
Polyglutamine expansion of huntingtin impairs its nuclear exportJonathan Cornett, Fengli Cao, Chuan-En Wang, et al.
Scientific Reports|November 8, 2019
Genetic deletion of S6k1 does not rescue the phenotypic deficits observed in the R6/2 mouse model of Huntington's diseaseElaine E Irvine, Loukia Katsouri, Florian Plattner, et al.
Brain Communications|February 19, 2024
Translatable plasma and CSF biomarkers for use in mouse models of Huntington's diseaseMarie K Bondulich, Jemima Phillips, María Cañibano-Pico, et al.
Brain Research Bulletin|March 14, 2007
The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypesBen Woodman, Rachel Butler, Christian Landles, et al.
Annals of Neurology|August 2, 2003
Minocycline and doxycycline are not beneficial in a model of Huntington's diseaseDonna L Smith, Benjamin Woodman, Amarbirpal Mahal, et al.
Scientific Reports|May 4, 2017
The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patientsAndreas Neueder, Christian Landles, Rhia Ghosh, et al.
The European Journal of Neuroscience|September 30, 2005
Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's diseaseEugenia Papalexi, Anna Persson, Maria Björkqvist, et al.
Neurobiology of Disease|April 20, 2005
A human single-chain Fv intrabody preferentially targets amino-terminal Huntingtin's fragments in striatal models of Huntington's diseaseTodd W Miller, Chun Zhou, Silvia Gines, et al.
Molecular Medicine (Cambridge, Mass.)|April 10, 2024
Correction: Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissuesFranziska Hoschek, Julia Natan, Maximilian Wagner, et al.
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Journal of Proteome Research|March 4, 2006
Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopyTsz M Tsang, Ben Woodman, Gerard A McLoughlin, et al.
Nature Genetics|January 18, 2005
Polyglutamine expansion of huntingtin impairs its nuclear exportJonathan Cornett, Fengli Cao, Chuan-En Wang, et al.
Scientific Reports|November 8, 2019
Genetic deletion of S6k1 does not rescue the phenotypic deficits observed in the R6/2 mouse model of Huntington's diseaseElaine E Irvine, Loukia Katsouri, Florian Plattner, et al.
Brain Communications|February 19, 2024
Translatable plasma and CSF biomarkers for use in mouse models of Huntington's diseaseMarie K Bondulich, Jemima Phillips, María Cañibano-Pico, et al.
Brain Research Bulletin|March 14, 2007
The Hdh(Q150/Q150) knock-in mouse model of HD and the R6/2 exon 1 model develop comparable and widespread molecular phenotypesBen Woodman, Rachel Butler, Christian Landles, et al.
Annals of Neurology|August 2, 2003
Minocycline and doxycycline are not beneficial in a model of Huntington's diseaseDonna L Smith, Benjamin Woodman, Amarbirpal Mahal, et al.
Scientific Reports|May 4, 2017
The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patientsAndreas Neueder, Christian Landles, Rhia Ghosh, et al.
The European Journal of Neuroscience|September 30, 2005
Reduction of GnRH and infertility in the R6/2 mouse model of Huntington's diseaseEugenia Papalexi, Anna Persson, Maria Björkqvist, et al.
Neurobiology of Disease|April 20, 2005
A human single-chain Fv intrabody preferentially targets amino-terminal Huntingtin's fragments in striatal models of Huntington's diseaseTodd W Miller, Chun Zhou, Silvia Gines, et al.
Molecular Medicine (Cambridge, Mass.)|April 10, 2024
Correction: Huntingtin HTT1a is generated in a CAG repeat-length-dependent manner in human tissuesFranziska Hoschek, Julia Natan, Maximilian Wagner, et al.
Pageof 15